-
专业包装 正品保证
-
快乐服务 售后无忧
-
会员特权 优惠不断
-
个人信息 严格保护
货号 | 规格 | 可用库存 | 销售价(RMB) | 您的折扣价(RMB) | 购买数量 |
---|
熔点: | |
---|---|
密度: | |
储存条件: | -20℃ |
Anti-PPP1CB antibody [A7-C7]
WB: 1:500-1:2,000
ICC: 1:50-1:200
IHC-P: 1:50-1:200
FC: 1:50-1:100
Fig1: Western blot analysis of PPP1CB on human PPP1CB recombinant protein using anti-PPP1CB antibody at 1/1,000 dilution.
Fig2: Western blot analysis of PPP1CB on HEK293 (1) and PPP1CB-hIgGFc transfected HEK293 (2) cell lysate using anti-PPP1CB antibody at 1/1,000 dilution.
Fig3: Western blot analysis of PPP1CB on different cell lysate using anti-PPP1CB antibody at 1/1,000 dilution.
Positive control: Line1: Jurkat Line2: A431 Line3: Hela Line4: HepG2 Line5: HEK293 Line6: MCF-7
Fig4: ICC staining PPP1CB (green) in MCF-7 cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Fig5: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using anti-PPP1CB antibody. Counter stained with hematoxylin.
Fig6: Immunohistochemical analysis of paraffin-embedded human rectum cancer tissue using anti-PPP1CB antibody. Counter stained with hematoxylin.
Fig7: Flow cytometric analysis of Hela cells with PPP1CB antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).
特别提示:本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!